GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: Adempas® | BAY 63-2521
                                 riociguat is an approved drug (FDA (2013), EMA (2014)) Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: Riociguat is the first-in-class stimulator of soluble guanylate cyclase (sGC) class of drugs.
                                    
                                 | 
 | |||||||||||||||||||||||||||||||||||
| Bioactivity Comments | 
| We have been unable to find publicly available bioactivity data for this drug at and sGC subunit to substantiate its MMOA, and have therefore not tagged a primary drug target. | 
| Selectivity at catalytic receptors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 
 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||